SLRN
ACELYRIN, INC. Common Stock
NASDAQ: SLRN · HEALTHCARE · BIOTECHNOLOGY
$2.27
+0.00% today
Updated 2026-04-30
Market cap
$229.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.69
Dividend yield
—
52W range
$2 – $3
Volume
4.1M
ACELYRIN, INC. Common Stock (SLRN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating cash flow | $-4.98M | $-61.52M | $-169.71M | $-303.92M |
| Capital expenditures | $25.00M | $0.00 | $12.29M | $1.25M |
| Depreciation | $0.00 | $0.00 | $115000.00 | $-17.99M |
| Stock-based comp | $233000.00 | $4.05M | $47.32M | $44.96M |
| Free cash flow | $-29.98M | $-61.52M | $-182.00M | $-305.17M |
| Investing cash flow | $-25.00M | $-47.87M | — | — |
| Financing cash flow | $124.72M | $274.26M | $568.44M | $5.39M |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |